Neogen Corporation Debt Securities, Trading, Unrealized Gain
Neogen Corporation (NEOG) reported Debt Securities, Trading, Unrealized Gain of $7.00 thousand for the 12-month period ending 2022-05-31, per its 10-K filed 2022-07-27.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesTradingUnrealizedGain · last filed 2022-07-27
- Neogen Corporation debt securities, trading, unrealized gain for the quarter ending 2022-05-31 was $0.00, a 100.00% decline year-over-year.
- Neogen Corporation debt securities, trading, unrealized gain for the quarter ending 2022-02-28 was -$73.00K.
- Neogen Corporation debt securities, trading, unrealized gain for the quarter ending 2021-11-30 was $20.00K.
- Neogen Corporation debt securities, trading, unrealized gain for the quarter ending 2021-08-31 was $60.00K, a 93.83% decline year-over-year.
- Neogen Corporation debt securities, trading, unrealized gain for fiscal 2022 was $7.00K, a 97.07% decline from fiscal 2021.
- Neogen Corporation debt securities, trading, unrealized gain for fiscal 2021 was $239.00K, a 58.58% decline from fiscal 2020.
- Neogen Corporation debt securities, trading, unrealized gain for fiscal 2020 was $577.00K.
| Period end | Debt Securities, Trading, Unrealized Gain 3 month | Debt Securities, Trading, Unrealized Gain 6 month | Debt Securities, Trading, Unrealized Gain 9 month | Debt Securities, Trading, Unrealized Gain 12 month |
|---|---|---|---|---|
| 2022-05-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | -$73.00K derived: sum of 2 quarters · filed 2022-07-27 | -$53.00K derived: sum of 3 quarters · filed 2022-07-27 | $7.00K 10-K · filed 2022-07-27 |
| 2022-02-28 | -$73.00K derived: 10-K 12 month − 3 quarters · filed 2022-07-27 | -$53.00K derived: sum of 2 quarters · filed 2022-07-27 | $7.00K 10-Q · filed 2022-04-01 | $12.00K derived: sum of 4 quarters · filed 2022-07-27 |
| 2021-11-30 | $20.00K 10-Q · filed 2021-12-30 | $80.00K derived: sum of 2 quarters · filed 2021-12-30 | $85.00K derived: sum of 3 quarters · filed 2022-07-27 | -$105.00K derived: sum of 4 quarters · filed 2022-07-27 |
| 2021-08-31 | $60.00K 10-Q · filed 2021-09-30 | $65.00K derived: sum of 2 quarters · filed 2022-07-27 | -$125.00K derived: sum of 3 quarters · filed 2022-07-27 | -$673.00K derived: sum of 4 quarters · filed 2022-07-27 |
| 2021-05-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-27 | -$185.00K derived: sum of 2 quarters · filed 2022-07-27 | -$733.00K derived: sum of 3 quarters · filed 2022-07-27 | $239.00K 10-K · filed 2022-07-27 |
| 2021-02-28 | -$190.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-31 | -$738.00K derived: sum of 2 quarters · filed 2021-03-31 | $234.00K 10-Q · filed 2021-03-31 | |
| 2020-11-30 | -$548.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-29 | $424.00K 10-Q · filed 2020-12-29 | ||
| 2020-08-31 | $972.00K 10-Q · filed 2020-09-30 | |||
| 2020-05-31 | $577.00K 10-K · filed 2021-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |